{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:01:41Z","timestamp":1792677701748,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.diabet.2025.101616","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T06:50:13Z","timestamp":1739083813000},"page":"101616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Continuous glucose monitoring\u2011derived time in range and CV are associated with elevated risk of adverse kidney outcomes for patients with type 2 diabetes"],"prefix":"10.1016","volume":"51","author":[{"given":"Qin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shucai","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2025.101616_bib0001","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","article-title":"KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease","volume":"98","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabet.2025.101616_bib0002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11892-018-0979-3","article-title":"Diabetic kidney disease: is there a role for glycemic variability?","volume":"18","author":"Subramanian","year":"2018","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.diabet.2025.101616_bib0003","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/dom.12976","article-title":"Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes","volume":"19","author":"Ceriello","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabet.2025.101616_bib0004","doi-asserted-by":"crossref","first-page":"e1804","DOI":"10.1097\/MD.0000000000001804","article-title":"Visit-to-visit glucose variability predicts the development of end-stage renal disease in type 2 diabetes: 10-year follow-up of Taiwan Diabetes Study","volume":"94","author":"Yang","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.diabet.2025.101616_bib0005","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.2337\/dc22-S006","article-title":"Glycemic targets: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101616_bib0006","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.2337\/dci21-0035","article-title":"Hemoglobin A(1c)-using epidemiology to guide medical practice: Kelly West Award Lecture 2020","volume":"44","author":"Selvin","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101616_bib0007","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.diabet.2025.101616_bib0008","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2337\/diab.44.8.968","article-title":"The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial","volume":"44","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2025.101616_bib0009","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.2337\/dc22-S011","article-title":"Chronic kidney disease and risk management: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101616_bib0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1681\/ASN.2010010031","article-title":"Diagnostic application of the A(1c) assay in renal disease","volume":"21","author":"Sharif","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabet.2025.101616_bib0011","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1089\/dia.2019.0499","article-title":"Association between continuous glucose monitoring-derived time in range, other core metrics, and albuminuria in type 2 diabetes","volume":"22","author":"Yoo","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabet.2025.101616_bib0012","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101616_bib0013","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/dc23-S006","article-title":"Glycemic targets: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101616_bib0014","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2025.101616_bib0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.numecd.2018.01.003","article-title":"Head-to-head comparison of the accuracy of Abbott FreeStyle Libre and Dexcom G5 mobile","volume":"28","author":"Boscari","year":"2018","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.diabet.2025.101616_bib0016","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2337\/diab.19.9.644","article-title":"Mean amplitude of glycemic excursions, a measure of diabetic instability","volume":"19","author":"Service","year":"1970","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2025.101616_bib0017","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101616_bib0018","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF01218495","article-title":"Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability","volume":"8","author":"Molnar","year":"1972","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2025.101616_bib0019","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/152091503322527021","article-title":"Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data","volume":"5","author":"Kovatchev","year":"2003","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabet.2025.101616_bib0020","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabet.2025.101616_bib0021","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1007\/s00125-012-2700-4","article-title":"HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study","volume":"55","author":"Hsu","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2025.101616_bib0022","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7326\/M20-0529","article-title":"Conversion of urine protein-creatinine ratio or urine dipstick protein to urine albumin-creatinine ratio for use in chronic kidney disease screening and prognosis: an individual participant-based meta-analysis","volume":"173","author":"Sumida","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabet.2025.101616_bib0023","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jamainternmed.2016.4687","article-title":"Efficacy of folic acid therapy on the progression of chronic kidney disease: the renal substudy of the China Stroke Primary Prevention Trial","volume":"176","author":"Xu","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.diabet.2025.101616_bib0024","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2025.101616_bib0025","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1038\/nrdp.2015.18","article-title":"Diabetic kidney disease","volume":"1","author":"Thomas","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.diabet.2025.101616_bib0026","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2337\/db08-0063","article-title":"Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients","volume":"57","author":"Ceriello","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2025.101616_bib0027","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.2337\/diabetes.52.11.2795","article-title":"Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation","volume":"52","author":"Quagliaro","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2025.101616_bib0028","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.2337\/dc15-1188","article-title":"Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis","volume":"38","author":"Gorst","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101616_bib0029","first-page":"38","article-title":"Comparison of glycemic variability and glycated hemoglobin as risk factors of coronary artery disease in patients with undiagnosed diabetes","volume":"125","author":"Mi","year":"2012","journal-title":"Chin Med J"},{"key":"10.1016\/j.diabet.2025.101616_bib0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12933-018-0683-2","article-title":"Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report","volume":"17","author":"Matsutani","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2025.101616_bib0031","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00592-013-0459-9","article-title":"Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes","volume":"50","author":"Sartore","year":"2013","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabet.2025.101616_bib0032","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00592-017-0971-4","article-title":"Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability","volume":"54","author":"Picconi","year":"2017","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabet.2025.101616_bib0033","doi-asserted-by":"crossref","first-page":"e3092","DOI":"10.1002\/dmrr.3092","article-title":"Continuous glucose monitoring defined glucose variability is associated with cardiovascular autonomic neuropathy in type 1 diabetes","volume":"35","author":"Jun","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabet.2025.101616_bib0034","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1253\/circj.CJ-15-0790","article-title":"Glycemic variability on continuous glucose monitoring system correlates with non-culprit vessel coronary plaque vulnerability in patients with first-episode acute coronary syndrome - optical coherence tomography study","volume":"80","author":"Gohbara","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.diabet.2025.101616_bib0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12933-021-01425-0","article-title":"Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study","volume":"20","author":"Andersen","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2025.101616_bib0036","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2337\/dc16-2426","article-title":"Association of glycemic variability in type 1 diabetes with progression of microvascular outcomes in the diabetes control and complications trial","volume":"40","author":"Lachin","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101616_bib0037","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1089\/dia.2019.0251","article-title":"Time in range is associated with carotid intima-media thickness in type 2 diabetes","volume":"22","author":"Lu","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabet.2025.101616_bib0038","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/dc20-1862","article-title":"Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study","volume":"44","author":"Lu","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101616_bib0039","doi-asserted-by":"crossref","first-page":"e2221","DOI":"10.1210\/clinem\/dgac034","article-title":"Complications of diabetes and metrics of glycemic management derived from continuous glucose monitoring","volume":"107","author":"Yapanis","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2025.101616_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108289","article-title":"TIR generated by continuous glucose monitoring is associated with peripheral nerve function in type 2 diabetes","volume":"166","author":"Li","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabet.2025.101616_bib0041","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/jdi.13811","article-title":"Comparison of glucose time in range and area under curve in range in relation to risk of diabetic retinopathy in type\u20092 diabetes patients","volume":"13","author":"Wang","year":"2022","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.diabet.2025.101616_bib0042","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/CM9.0000000000001740","article-title":"Association between time in range and cancer mortality among patients with type 2 diabetes: a prospective cohort study","volume":"135","author":"Shen","year":"2021","journal-title":"Chin Med J"},{"key":"10.1016\/j.diabet.2025.101616_bib0043","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/dme.12607","article-title":"Association between the extent of urinary albumin excretion and glycaemic variability indices measured by continuous glucose monitoring","volume":"32","author":"Jin","year":"2025","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2025.101616_bib0044","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.diabet.2025.101616_bib0045","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1681\/ASN.2008050514","article-title":"RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes","volume":"20","author":"Coughlan","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabet.2025.101616_bib0046","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejphar.2018.06.001","article-title":"AGE-RAGE axis blockade in diabetic nephropathy: current status and future directions","volume":"833","author":"Sanajou","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.diabet.2025.101616_bib0047","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00125-011-2049-0","article-title":"Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells","volume":"54","author":"Schisano","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2025.101616_bib0048","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s11892-013-0383-y","article-title":"Glycemic memories and the epigenetic component of diabetic nephropathy","volume":"13","author":"Keating","year":"2013","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.diabet.2025.101616_bib0049","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.2337\/db17-0294","article-title":"Impact of glycemic variability on chromatin remodeling, oxidative stress, and endothelial dysfunction in patients with type 2 diabetes and with target HbA(1c) levels","volume":"66","author":"Costantino","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2025.101616_bib0050","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/dia.2017.0455","article-title":"Optimal sampling duration for continuous glucose monitoring to determine long-term glycemic control","volume":"20","author":"Riddlesworth","year":"2018","journal-title":"Diabetes Technol Ther"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363625000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363625000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T04:41:36Z","timestamp":1740717696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363625000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1262363625000126"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2025.101616","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous glucose monitoring\u2011derived time in range and CV are associated with elevated risk of adverse kidney outcomes for patients with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2025.101616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101616"}}